Abstract | OBJECTIVE: DESIGN: RESULTS: The percentage improvement in the clinical severity scores after inhalation therapy was not significant in group 1 on the first, second, and third days after hospital admission (3.5%, 2%, and 4%, respectively). In group 2, significant improvement was observed on these days (7.3%, 8.9%, and 10%, respectively; p < 0.001). Also, the improvement in clinical severity scores differed significantly on each of these days between the two groups. Using 3% saline solution decreased the hospitalization stay by 25%: from 4 +/- 1.9 days in group 1 to 3 +/- 1.2 days in group 2 (p < 0.05). CONCLUSIONS:
|
Authors | Avigdor Mandelberg, Guy Tal, Michaela Witzling, Eli Someck, Sion Houri, Ami Balin, Israel E Priel |
Journal | Chest
(Chest)
Vol. 123
Issue 2
Pg. 481-7
(Feb 2003)
ISSN: 0012-3692 [Print] United States |
PMID | 12576370
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Aerosols
- Saline Solution, Hypertonic
- Epinephrine
|
Topics |
- Acute Disease
- Aerosols
- Bronchiolitis, Viral
(therapy)
- Dose-Response Relationship, Drug
- Double-Blind Method
- Epinephrine
(administration & dosage)
- Female
- Hospitalization
- Humans
- Infant
- Infant, Newborn
- Male
- Nebulizers and Vaporizers
- Oxygen Inhalation Therapy
- Saline Solution, Hypertonic
(administration & dosage)
- Treatment Outcome
|